Katarzyna Pierzchala1, Dunja Simicic1, Andrzej Sienkiewicz2, Dario Sessa3, Stefanita Mitrea4, Olivier Braissant5, Valerie McLin3, Rolf Gruetter1, and Cristina Cudalbu4
1CIBM / LIFMET / EPFL, Lausanne, Switzerland, 2LPMC / EPFL, Lausanne, Switzerland, 3Center for Liver Disease in Children,Department of Paediatrics, HUG, Geneva, Switzerland, 4CIBM / EPFL, Lausanne, Switzerland, 5Service of Clinical Chemistry, CHUV, Lausanne, Switzerland
Synopsis
Chronic hepatic encephalopathy (CHE) is a
multifactorial disease. The presence of central nervous system (CNS) and
systemic oxidative stress (OS) is thought to contribute to the pathogenesis of
CHE. Clinically, it is known that peripheral inflammation contributes to acute
worsening of patients with CHE. We used in-vivo
1H-MRS, ex-vivo/in-vitro
ESR and histology of CNS to investigate longitudinally the course of OS in the
rat model of CHE. Our studies revealed antioxidant system impairment (decrease
of CNS Asc and GSH, post-BDL) and increased CNS and systemic OS over the course
of CHE progression, concomitant with CNS Gln and systemic NH4+ increase.
PURPOSE
The central nervous system(CNS) has a
very active-oxidative-metabolism compared with other organs1,2.Physiological
levels of reactive-oxygen-species(ROS) act as cellular secondary messengers. When
in excess, become neurotoxic and are involved in neurodegeneration.
The presence of CNS and systemic-OS
contribute to the pathogenesis of CHE3.
Moreover,peripheral-inflammation and systemic-OS lead to acute worsening of CHE
patients4.Impaired
ammonium clearance by the diseased liver leads to brain glutamine(Gln) accumulation
in CHE, inducing in-vitro-ROS
generation associated with astrocyte deterioration5,6.In addition,hyperammonemia impairs neutrophils
function by decreasing phagocytosis and increasing spontaneous-oxidative-burst7.
In a rat-model of CHE(bile-duct-ligated,BDL-rat)
we have demonstrated by 1H-MRS the indirect presence of OS(i.e. decrease
of brain ascorbate(Asc) and glutathione(GSH) in hippocampus, together with the
early increase in plasma ammonium and brain Gln,suggestive of oxidative/osmotic
stress8,9.Furthermore we have validated the OS findings using for
the first time ex-vivo-ESR at a late-time-point
in disease evolution10.
The novelty of the present study
relies on the longitudinal assessment of hippocampal and systemic-OS using a
multimodal approach:in-vivo 1H-MRS
followed by ex-vivo/in-vitro-ESR
detection of ROS and histological measures.METHODS
In-vivo 1H-MRS
A new group of Wistar male-adult-rats was BDL or
sham-operated and measured before BDL(n=23) and after every 2-weeks up to 8-weeks(n=7).In-vivo 1H-MRS
(9.4T,Varian/Magnex-Scientific) was used to analyze neurometabolism including antioxidant
concentrations in the hippocampus(2x2.8x2mm3) using SPECIAL-sequence11(TE=2.8ms,TR=4sec;160averages).Metabolite
concentrations were calculated by LCModel using water as reference.
Ex-vivo/in-vitro-ESR
ESP300E(Bruker-BioSpin,TE102-cavity) was
used to measure the concentration and time-course of ROS in hippocampus
and blood.The hippocampus
was extracted/weighed/sliced and transferred into RPMI1640-medium(37oC)
with 10mM-CMH-cell-permeable non-toxic spin-trap(Noxygen-GmbH). Blood(1mL) was collected
and CMH-spin-trap was added(10mM final-concentration).After each incubation-time,
tissue-suspension/blood was transferred into quartz-capillary and measured.
Neurohistology-Golgi-Cox-method
Golgi-Cox-staining uses the principle of metallic-impregnation
of neurons and it was applied to reveal detailed neuronal morphology of the hippocampus.110μm-thick
brain sections were cut sagittally(25 slides/hemisphere,n=8).
Lymphocytes/Polymorphonuclear cells (PMNs) count
Sterile-blood was obtained from heart(n=20). 7ml of
anticoagulated-blood was used for each isolation procedure. Acridine-Orange-assay
was applied to assess the lymphocytes and PMNs concentrations.
RESULTS AND DISCUSSION
The presence of chronic liver
disease was confirmed by increased plasma ammonium and bilirubin(2-weeks-post-BDL).
1H-MRS revealed
the well-known ammonium-induced increase in Gln(+67%,4-weeks-post-BDL) together
with the decrease in brain osmolytes(Fig1A-B). Astrocytes are essential to
detoxify ammonium12,while Gln increase is known to produce OS
response in cells13.In
this context,we have previously shown a global atrophy of astrocytes in BDL-rats8,9,suggesting an astrocytic activation
and synaptic depression induction14.
The main antioxidants measured by
1H-MRS showed a decrease at 4-weeks-post-BDL:Asc -11%, GSH -10%,
reaching -17% at 8-weeks(Fig1C). Of note, the previously observed Asc decrease
at 8-weeks-post-BDL was absent, probably due to the smaller number of rats.The
hippocampus ex-vivo-ESR revealed a
significant increase of OS +68%(p<0.01) already at 2-weeks-post-BDL,thereby
enhancing the time-resolution and understanding of neurometabolic changes in
early CHE relative to 1H-MRS.
ROS as signaling and stress-molecules
affect synaptic-plasticity and are critical for long-term-potentiation(LTP) in
the hippocampus,,a form of synaptic-plasticity for learning/memory but are also
involved in aging-related-impairment the long-term-depression(LTD)15,16.Dismutation
of superoxide-anion generates H2O2
in hippocampal neurons, affecting LTP in complex ways.The excess of ROS
attenuates LTP and synaptic neurotransmission17,18.
In-vitro-ESR on peripheral-blood demonstrated
a significant increase of systemic OS(+49%,6-weeks-post-BDL).These
results are consistent with the increase in the peripheral white-blood-cells
count: lymphocytes:+177%,PMNs:+78% at 2-weeks-post-BDL. Ammonia induced PMNs swelling7 was detected already
at 2-weeks-post-BDL.This is a sign of impaired
phagocytosis and increased prevalence of spontaneous-oxidative-burst7(Fig.2D).This
finding may be in keeping with the known vulnerability to infection in
cirrhosis and the consequent risk for HE decompensation.
The Golgi-Cox-staining showed a significant
increase in CA1(~67%, p<0.001) and DG(~54%,p<0.001) neuronal-soma surface
and a significant loss of dendritic-spines-density in CA1~49%(apical,basal,p<0.001)
and DG~43%(apical,p<0.001) in hippocampal neurons(Fig.3).It’s known that
different neurons have different levels of vulnerability to OS.The
hippocampus,amygdala,and cerebellar granule cells have been reported as the
most susceptible and therefore may the first to exhibit functional decline19.In
addition NAA(showing -9% decrease by 1H-MRS) may be a minor
contributor to neuronal volume-regulation which responds to hypo-osmolarity and acts as a co-transit substrate for a putative
molecular-water-pump to remove excess of water from neurons20.
Furthermore, the hippocampus
plays a critical role in several higher brain functions, such as
learning/memory, spatial-encoding and is one of the few brain regions which exhibits
adult-neurogenesis21.The alterations of hippocampus neuronal
morphology due to metabolic-degenerative-disorders are often associated with
cognitive impairment, suggesting that the hippocampus may be an interesting
area to study in HE.CONCLUSIONS
The present
study shows the potential of multidisciplinary-approach to monitor longitudinally central
and systemic-OS in a rat-model of CHE using
in-vivo 1H-MRS combined with ex-vivo/in-vitro-ESR
spectroscopy. The presence of hippocampal and systemic-OS was measured early,i.e.2-weeks post-BDL. Moreover, the 1H-MRS
findings were validated by ex-vivo-ESR.
Our previously depicted astroglia atrophy8,9 may cause reduction in network
connectivity, synaptic coverage and homeostatic capabilities24.These results corroborate
with the present Golgi-Cox-staining showing significant increase of hippocampal
neuronal soma surface and dendritic-spines-density loss.Therefore, it’s
tempting to extrapolate that high OS levels are associated with a loss of neurons
connectivity associated with behavioral deterioration in a rat-model of CHE. Acknowledgements
Supported by
CIBM of the UNIL, UNIGE, HUG, CHUV, EPFL, the Leenaards and Jeantet Foundations
and the SNSF project no 310030_173222/1References
1Halliwell B. J Neurochem 59: 1609–1623,1992;2 Samina Salim, J Pharmacol Exp Ther 360:201–205, 2017; 3Bosoi CR, Rose CF.
Metab Brain Dis. 2013 Jun;28(2):175-8;4Cristina
R. Bosoi, Christopher F. Rose, Metabolic Brain Disease,2012; 5Skowronska M. and
Albrecht J., Neurochemistry International, 2012;6Lachman V. et al.,
Archives of Biochemistry and Biophysics, 2013; 7Debbie L.
Shawcross et al., HEPATOLOGY, Vol. 48, No. 4,
2008; 8K. Pierzchala et al., ISMRM2019 # 2279; 9Olivier Braissant, et al.,Journal of Hepatology 2019; 10K. Pierzchala et al.,
ISMRM2018 # 448; 11Mlynárik
et al, Magn Reson Med 2006;
12Gavin A. K. et al., Liver Int. 2014: 34: 1184–1191; 13Jan Albrecht
and Michael D. Norenberg, HEPATOLOGY 2006;44:788-794; 14Rogier Min & Thomas Nevian, 2012 nature
NEUROSCIENENCE; 15Lauren T. Knapp and Eric Klann, Journal of Neuroscience Research, 2002;16Cynthia
A.et al., PNAS 2009 August, 106 (32) 13576-13581; 17Mol Neurobiol(2017); 18Xinkun Wang and Elias K. Michaelis,Frontiers in Aging Neuroscience, 2010; 19Wang X and
Michaelis EK, Front Aging Neurosci 2:12(2010); 20Brian Ross
et al.,Progress in Neurobiology 81 (2007); 21Peter Jonas and John Lisman, Frontiers in Neural
Circuits, September 2014; 22Bruna
Bellaver et al.,Mol Neurobiol,2017;23Cecilia Hidalgo and Alejandra Arias-Cavieres
PHYSIOLOGY • Volume 31 • May 2016;
24Alexei
Verkhratsky, José J. Rodríguez, and Luca Steardo, The Neuroscientist 2014.